Ernest Baldwin, MD
Endocrinology, Diabetes & Metabolism · Salt Lake City, UTNPI 1215978234
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Dexcom, Inc. accounts for 82.4% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in UT, where the typical reported total is $3,842.
Across 7 payments — averaging $13.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$79
- Tandem Diabetes Care, Inc.$17
What the payments were for
- Food & beverage$95100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 6 | $79 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
How this compares
$95 in reported general payments places this provider in the 20th percentile of 38 endocrinology, diabetes & metabolism providers in Utah.
See all endocrinology, diabetes & metabolism providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 54 | $65,597 |
| JardianceEmpagliflozin | 16 | $21,468 |
| Cinacalcet Hcl | 37 | $7,828 |
| SynthroidLevothyroxine Sodium | 41 | $4,304 |
| Levothyroxine Sodium | 336 | $4,217 |
| Cabergoline | 16 | $3,698 |
| Hydrocortisone | 50 | $3,285 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $3,187 |
| Testosterone | 20 | $2,523 |
| Fludrocortisone Acetate | 35 | $1,139 |
| Testosterone Cypionate | 14 | $860 |
| Alendronate Sodium | 90 | $808 |
| Methimazole | 48 | $562 |
| Losartan Potassium | 26 | $374 |
| Prednisone | 19 | $367 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Salt Lake City
- Eliot BrintonSalt Lake City$733K
- Alireza Falahati-NiniSalt Lake City$241K
- Shahzad AhmadSalt Lake City$25K
- Vishnu SundareshSalt Lake City$18K
- Bruce BradySalt Lake City$5K
- Barry BenowitzSalt Lake City$4K
- Marie CouldwellSalt Lake City$3K
- Kelsey DesalvoSalt Lake City$3K
- Sneha WagleSalt Lake City$257
- Javier Munoz BarreraSalt Lake City$160
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.